We finally have more options for people with Alzheimer’s. But those options only matter if they reach patients in time.

Eyewitness News' Bill Ritter led a powerful discussion Wednesday night to raise awareness about Alzheimer's disease.

Not all researchers are convinced that the brain changes detected via MRI are robust enough to become a diagnostic tool. But ...

A collaborative study led by researchers in Arizona found that a new blood test improves early detection of Alzheimer's ...

The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

Medically reviewed by Smita Patel, DO Key Takeaways Anti-amyloid medications taken in early-stage Alzheimer’s may slow ...

The test can spot the brain plaques that define Alzheimer’s long before a diagnosis would normally be on the table.

The finding in human cerebrospinal fluid also raises the possibility of using meprin-β as an indicator of Alzheimer’s. This ...

The Alzheimer’s risk gene APOE4 may actively damage brain blood vessels and sabotage the cellular systems that remove harmful ...

A new mathematical model explores how metals such as copper and zinc may shape the aggregation of amyloid-beta, a protein ...

The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.